CCRM

Commercializing Living Therapies with CCRM

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

Vizitează neapărat site-ul podcastului și susține-i creatorul: www.ccrm.ca

Autor

CCRM

Categorie

Science

Site-ul podcastului

www.ccrm.ca

Cel mai nou episod

15 oct. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

Moving from A to B 14.02.2022

Manufacturing and supply chain issues in cell and gene therapies.    Featuring:  Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting  Rob Jones, Vice President, Global Bioservices, Cryoport Systems   It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony...

Chaperoning innovation through the valley of death 14.01.2022

The business of regenerative medicine and investment.   Featuring:  Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises  Geoff MacKay, President and CEO, AVROBIO  Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Jo...

The importance of educating the public about cell and gene therapies 14.12.2021

How can the regenerative medicine community create broader societal awareness?  Featuring:  Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem...

Ascultă podcastul Commercializing Living Therapies with CCRM în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice